Sign up for a recorded ExpertED@SSO webinar and watch it on any device at your convenience. Recent educational webinars include programs in melanoma, breast and colorectal cancer disease sites. Watch one of the webinars listed below or explore other titles by disease site at Surgonc.org/ExpertED.
Radiation Following Breast Surgery
Faculty: David Brenin, MD, Kandace P. McGuire, MD, FACS, Anees Chagpar, MD, MSc, MPH, MA, MBA, FRCS(C), FAC
There is a need for surgical oncologists to be educated on the results with these new genomic classifiers that have recently become commercially available in order to properly counsel their patients about the pros and cons of receiving radiation following breast conserving surgery.
You may find this activity in the Breast Disease section in the ExpertED@SSO catalog.
Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?
Faculty: Julie Margenthaler, MD and Sarah McLaughlin, MD
Based on the SSO 2019 Great Debate, this webinar will present data and compare and contrast the benefits and limitations of upfront surgery and neoadjuvant therapy for resectable HER2+/TNBC.
You may find this activity in the Breast Disease section in the ExpertED@SSO catalog.
This activity is partially supported by an independent educational grant from Genentech.
Young Adult Onset Colorectal Cancer: What is going on?
Faculty: J. Joshua Smith, MD, PhD, Y. Nancy You, MD, MHSc, and Heather Yeo, MD, MHS.
Young-onset colorectal cancer is distinct in many ways. Location of the tumor varies substantially with age and cancers are also histologically more aggressive. This webinar will review practice changing papers and national screening guidelines and age-related differences in colorectal cancer that have implications for diagnosis and treatment.
You may find this activity in the Colorectal Disease section in the ExpertED@SSO catalog.
Breast Cancer: Genetic Testing and Management
Faculty: Marissa Howard-McNatt, MD, David Euhus, MD, Thuy Vu, MS, CGC, Brittany Puster
In this webinar, based on the SSO 2019 session, participants will learn about newly identified hereditary genetic mutations that put a patient at a higher risk for breast cancer. The content covered will include what genetic tests to order along with the appropriate treatment options for patients with certain genetic mutations.
You may find this activity in the Breast Disease section in the ExpertED@SSO catalog.
Multi-Modality Management of Stage IV Melanoma in the Era of Immunotherapy
Faculty: Omid Hamid, MD, Genevieve Boland, MD, PhD, Mark Faries, MD and Charlotte Ariyan, MD
Learn about the mechanisms of action and toxicities of novel immunotherapeutic agents for metastatic melanoma and how to best integrate these agents with surgical options. Four specific topics will be covered including: systemic therapy, immune adjuvants for Stage IV melanoma, management of oligometastatic disease and surgical outcomes in melanoma in combination with immunotherapy.
You may find this activity in the Melanoma Disease section in the ExpertED@SSO catalog.
This activity is partially supported by independent educational grants from Amgen, Bristol Myers Squibb and Merck.